pharmaceutical

Upadacitinib shows promise for papulopustular rosacea in pilot study

‘Major step forward’: TGA approves first pharmacological therapy for OSA

New consensus for JAKi use in AD

Oral JAKi improves phototherapy-induced repigmentation in vitiligo

Dupilumab for chronic spontaneous urticaria gets tick

Eli Lilly exec says slow PBS threatens clinical trials funding

TGA and international partners prioritise joint product reviews

Deprescribe, use the patient’s stash and shrink starter packs
